Back to Search
HARRY EARL, M.D.
M.D.
Allergy & Immunology Physician
NPI: 1609886498Individual
Specialties, Licenses & Credentials
Allergy & Immunology PhysicianPrimary
Allergy & Immunology
Code: 207K00000X
F9389(TX)
Research & Publications (20)
Apparent diffusion coefficient and vascular signal fraction measurements with magnetic resonance imaging: feasibility in metastatic ovarian cancer at 3 Tesla: technical development.
PMID 19657643·Eur Radiol·2010
8-other
Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial.
PMID 19447249·Lancet·2009
3-trial
Non-pineal supratentorial primitive neuro-ectodermal tumors (sPNET) in teenagers and young adults: Time to reconsider cisplatin based chemotherapy after cranio-spinal irradiation?
PMID 19202566·Pediatr Blood Cancer·2009
3-trial
Image-guided biopsy in patients with suspected ovarian carcinoma: a safe and effective technique?
PMID 18704437·Eur Radiol·2009
3-trial
Metabolic characterization of primary and metastatic ovarian cancer by 1H-MRS in vivo at 3T.
PMID 19645005·Magn Reson Med·2009
8-other
tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmonary, cardiac and hepatic function evaluation.
PMID 18665163·Br J Cancer·2008
3-trial
NEAT: National Epirubicin Adjuvant Trial--toxicity, delivered dose intensity and quality of life.
PMID 18797468·Br J Cancer·2008
3-trial
The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel.
PMID 18068629·Cancer Cell·2007
8-other
Laboratory handling and histology reporting of breast specimens from patients who have received neoadjuvant chemotherapy.
PMID 17448015·Histopathology·2007
6-review
A study to evaluate the use of CA125 in ovarian cancer follow-up: A change in practice led by patient preference.
PMID 16445969·Gynecol Oncol·2006
8-other
Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer.
PMID 17079759·N Engl J Med·2006
3-trial
Blood transfusion requirements for patients with sarcomas undergoing combined radio- and chemotherapy.
PMID 18521418·Sarcoma·2005
8-other
Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: an anglo-celtic cooperative oncology group study.
PMID 15860854·J Clin Oncol·2005
3-trial
A review of the surgical management of metastatic gastrointestinal stromal tumours (GISTs) on imatinib mesylate (Glivec).
PMID 17462285·Int J Surg·2005
8-other
Barriers to effective communication across the primary/secondary interface: examples from the ovarian cancer patient journey (a qualitative study).
PMID 16098121·Eur J Cancer Care (Engl)·2005
8-other
Safety of cephalosporin administration to patients with histories of penicillin allergy.
PMID 15214363·J Allergy Clin Immunol·2004
8-other
Somatization disorder and cancer: a case history and review.
PMID 16594404·Palliat Support Care·2004
5-case
Estimating photosynthetic electron transport via chlorophyll fluorometry without Photosystem II light saturation.
PMID 16151873·Photosynth Res·2004
8-other
Epirubicin as adjuvant therapy in breast cancer.
PMID 15056049·Expert Rev Anticancer Ther·2004
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5421 MATLOCK RD
ARLINGTON, TX 76018 - Phone
- (817) 460-7447
Quick Facts
- NPI
- 1609886498
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile